Practice Areas - Debt Capital Markets Law Firms and Lawyers
Deal Date: | 17-08-2015 | Practice Area: | Debt Capital Markets |
Deal Title: | PTC Therapeutics Convertible Senior Notes due 2022, | Industry: | Pharmaceuticals & Biotechnology |
Description: |
Davis Polk advised the joint bookrunning managers and representatives of the initial purchasers in connection with a Rule 144A offering by PTC Therapeutics, Inc. of USD150 million aggregate principal amount of 3.00% convertible senior notes due 2022, which included USD25 million aggregate principal amount of notes from the full exercise of the initial purchasers' option to purchase additional notes.
The Davis Polk capital markets team included partners Richard D. Truesdell Jr. and Sophia Hudson and associates Yasin Keshvargar and Martin Oberst.
|
||
Financial Center: | New York | Value: | 100.01-500.00 |
Advised Party: | Underwriter | Law Firm | Davis Polk |
Issuer Jurisdiction: | United States | Listing Jurisdiction: | United States |
Classification: |
Equity-Linked Securities Convertible Bonds |
Lawyer | Richard D Truesdell Jr |